The BETTER-B clinical trial found that patients with COPD and ILDs using mirtazapine for breathlessness vs placebo had slightly increased adverse events and care use. Among patients with chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback